fashion -WSS

fashion

author：comprehensive 2025-10-02 13:40:42 - browse：9898

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

WSS

TikTok cracks down on users posting about weight loss drugs

Trump got a 'target letter.' What is one and what does it mean?

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Celebrate National Dole Whip Day for 3 days this week at Disney

DOJ, FTC to increase scrutiny of all types of health care mergers

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Tori Bowie and the unacceptable rates of Black maternal death

DOJ, FTC to increase scrutiny of all types of health care mergers

Alkermes shareholders re

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Living organ donors deserve priority status for transplants

Sports medicine is finally prioritizing gender equality

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Sports medicine is finally prioritizing gender equality

Novo: Oral version of Ozempic leads to 15% weight loss

focus

Stanford president to resign after investigation of research

A public health expert passes on football's full body collisions for youths

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Resistance to cancer drugs: A new genetic explanation

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Sea level rise could wash away turtle breeding grounds around the world, researchers say

hotspot

entertainment

knowledge

knowledge